• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

圣保罗州新冠疫情的演变:2020年至2023年发病率、死亡率及致死率分析

Evolution of COVID-19 in the State of São Paulo: Analysis of Incidence, Mortality and Lethality from 2020 to 2023.

作者信息

Martire Junior Lybio Jose, Pereira Gabrielle do Amaral Virginio, Cavalcante Matheus Paiva Emidio, Barreto Yasmin Esther, Macedo Hugo, Figueira Fernando Augusto Marinho Dos Santos, Andrade Romildo Luiz Monteiro, de Abreu Luiz Carlos

机构信息

Postgraduate Program in Health Sciences, Centro Universitário da Faculdade de Medicina do ABC, Santo André 09060-650, SP, Brazil.

COVID-19 Observatory Brazil and Ireland, School of Medicine, University of Limerick, V94 T9PX Limerick, Ireland.

出版信息

Epidemiologia (Basel). 2025 Feb 6;6(1):6. doi: 10.3390/epidemiologia6010006.

DOI:10.3390/epidemiologia6010006
PMID:39982258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11843986/
Abstract

INTRODUCTION

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus, which belongs to the coronavirus family. SARS-CoV-2 is related to other viruses that cause severe acute respiratory syndrome. The emergence of cases of pneumonia of unknown origin triggered the largest viral pandemic in modern times, presenting major challenges to global public health.

OBJECTIVE

To analyze the evolution of the COVID-19 pandemic in the state of São Paulo from 2020 to 2023, focusing on trends in incidence, mortality, and lethality.

METHODS

Ecological study of time series of incidence, mortality and lethality by COVID-19 in the state of São Paulo using Prais-Winsten regression considering the Weekly Percentage Change (WPC) and probability values (p), considering a significance level of 95% (95% CI). To ensure the reliability of the entered data, double-blind typing was performed by different researchers in the same database extracted from the 2024 Ministry of Health Coronavirus dashboard.

RESULTS

From February 2020 and the end of December 2023, 6,763,310 accumulated cases and 182,254 deaths were recorded. Stationary trends were observed for the year 2022, with a reduction in incidence and mortality in the year 2023. However, the epidemiological variable lethality showed a stationary trend.

CONCLUSION

The analysis of the trends in incidence, mortality, and lethality revealed variable dynamics over time, with emphasis on the significant reduction of these indicators in 2023.

摘要

引言

新冠病毒病(COVID-19)是一种由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的呼吸道疾病,SARS-CoV-2属于冠状病毒科。SARS-CoV-2与其他导致严重急性呼吸综合征的病毒有关。不明原因肺炎病例的出现引发了现代史上最大规模的病毒大流行,给全球公共卫生带来了重大挑战。

目的

分析2020年至2023年圣保罗州新冠病毒病大流行的演变情况,重点关注发病率、死亡率和致死率的趋势。

方法

采用普雷斯-温斯坦回归法,考虑周百分比变化(WPC)和概率值(p),以95%(95%置信区间)的显著性水平,对圣保罗州新冠病毒病的发病率、死亡率和致死率时间序列进行生态研究。为确保输入数据的可靠性,由不同研究人员对从2024年卫生部冠状病毒信息平台提取的同一数据库进行双盲录入。

结果

从2020年2月至2023年12月底,共记录了6763310例累计病例和182254例死亡病例。2022年观察到平稳趋势,2023年发病率和死亡率有所下降。然而,流行病学变量致死率呈平稳趋势。

结论

对发病率、死亡率和致死率趋势的分析揭示了随时间变化的不同动态,重点是2023年这些指标的显著下降。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa16/11843986/b248aa969dad/epidemiologia-06-00006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa16/11843986/b248aa969dad/epidemiologia-06-00006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa16/11843986/b248aa969dad/epidemiologia-06-00006-g001.jpg

相似文献

1
Evolution of COVID-19 in the State of São Paulo: Analysis of Incidence, Mortality and Lethality from 2020 to 2023.圣保罗州新冠疫情的演变:2020年至2023年发病率、死亡率及致死率分析
Epidemiologia (Basel). 2025 Feb 6;6(1):6. doi: 10.3390/epidemiologia6010006.
2
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
3
Risk of Incidence and Lethality by Etiology of Severe Acute Respiratory Syndrome in Hospitalized Children Under 1 Year of Age in Brazil in 2024: A Cross-Sectional Study.2024年巴西1岁以下住院儿童严重急性呼吸综合征病因的发病率和致死率风险:一项横断面研究
Trop Med Infect Dis. 2025 Jun 14;10(6):168. doi: 10.3390/tropicalmed10060168.
4
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
5
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
6
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
9
Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.长期护理机构中实施的非药物措施以预防 SARS-CoV-2 感染及其后果:快速综述。
Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD015085. doi: 10.1002/14651858.CD015085.pub2.
10
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦片/利托那韦片组合包装用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2.

本文引用的文献

1
Lessons Learned from the COVID-19 Pandemic: Interpreting Vaccination Strategies in a Nationwide Demographic Study.从新冠疫情中吸取的教训:在一项全国性人口研究中解读疫苗接种策略
Vaccines (Basel). 2024 May 26;12(6):581. doi: 10.3390/vaccines12060581.
2
COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type.COVID-19 发病率与区域检测策略、疫苗接种覆盖率和疫苗类型的关系。
Viruses. 2023 Oct 30;15(11):2181. doi: 10.3390/v15112181.
3
Temporal Analysis of COVID-19 Epidemiological Indicators in a Low-Income Brazilian Context: A Retrospective Analysis in Paraiba State.
巴西低收入背景下 COVID-19 流行病学指标的时间分析:帕拉伊巴州的回顾性分析。
Viruses. 2023 Sep 28;15(10):2016. doi: 10.3390/v15102016.
4
Relationship between primary vaccination coverage and booster coverage against COVID-19, socio-economic indicators, and healthcare structure in Brazil.巴西首剂疫苗接种覆盖率和加强针接种覆盖率与社会经济指标和医疗保健结构的关系。
Public Health. 2023 Jul;220:108-111. doi: 10.1016/j.puhe.2023.05.003. Epub 2023 May 10.
5
Tracking the COVID-19 vaccines: The global landscape.追踪 COVID-19 疫苗:全球形势。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2191577. doi: 10.1080/21645515.2023.2191577. Epub 2023 Mar 30.
6
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies.全球新兴的 SARS-CoV-2 奥密克戎变异株:影响、挑战与策略。
J Infect Public Health. 2023 Jan;16(1):4-14. doi: 10.1016/j.jiph.2022.11.024. Epub 2022 Nov 19.
7
COVID-19 mortality rate determinants in selected Eastern European countries.部分东欧国家新冠病毒疾病的死亡率决定因素
BMC Public Health. 2022 Nov 16;22(1):2088. doi: 10.1186/s12889-022-14567-x.
8
[COVID-19 in Brazil: trends, challenges, and perspectives after 18 months of the pandemicCOVID-19 en Brasil: tendencias, desafíos y perspectivas después de 18 meses de pandemia].[巴西的新冠疫情:大流行18个月后的趋势、挑战与展望 巴西的新冠疫情:大流行18个月后的趋势、挑战与展望]
Rev Panam Salud Publica. 2022 Jul 20;46:e74. doi: 10.26633/RPSP.2022.74. eCollection 2022.
9
Comorbidities and covid-19.合并症与新冠病毒病
BMJ. 2022 Jun 15;377:o1431. doi: 10.1136/bmj.o1431.
10
[Changes in the pattern of COVID-19 hospitalizations and deaths after substantial vaccination of the elderly in Manaus, Amazonas State, Brazil].[巴西亚马孙州玛瑙斯市老年人大规模接种疫苗后新冠病毒肺炎住院和死亡模式的变化]
Cad Saude Publica. 2022 May 16;38(5):PT192321. doi: 10.1590/0102-311XPT192321. eCollection 2022.